Used by patients in the Netherlands since 2003, Bedrocan® standardised cannabis flos is now available for patients in Australia. This includes the same cannabis flos currently used in the NSW palliative care clinical trial.
Administered by vaporization, the consistent chemical profile of the flos better allows doctors to monitor dosage, condition progress, and reduce the risk of overdosing and unwanted side effects.
Being free of microbial contaminants (molds, fungi, and bacteria), pesticides, and heavy metals, Bedrocan cannabis flos is safe for vaporization and inhalation into the lungs. These qualities are especially important for people with weakened immune systems.
The recently published Prescribing Bedrocan provides information to assist health professionals on dosing, safety, and side effects. Our portal now allows doctors to report adverse events online.
Novachem, a specialist import and distribution agent, will supply flos and vaporization technology to licensed pharmacies in Australia.